The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Human Varicella-Zoster Immunoglobulin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Human Varicella-Zoster Immunoglobulin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1753906

No of Pages : 93

Ask Your Query

Synopsis
The global Human Varicella-Zoster Immunoglobulin market size was valued at USD 163.6 million in 2022 and is forecast to a readjusted size of USD 204 million by 2029 with a CAGR of 3.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Herpes zoster is an acute herpetic viral skin disease caused by the varicella-zoster virus that involves the nerves and skin. Infected individuals treated with human water were less likely to develop severe varicella-zoster virus than those not treated with it.

Human varicella-zoster immune globulin is a solution of antibodies used for post exposure prophylaxis of varicella infections in high risk populations, as well as to reduce the severity of infections.

This report is a detailed and comprehensive analysis for global Human Varicella-Zoster Immunoglobulin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

  • Global Human Varicella-Zoster Immunoglobulin market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
  • Global Human Varicella-Zoster Immunoglobulin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
  • Global Human Varicella-Zoster Immunoglobulin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
  • Global Human Varicella-Zoster Immunoglobulin market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Human Varicella-Zoster Immunoglobulin
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace

This report profiles key players in the global Human Varicella-Zoster Immunoglobulin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

Key companies covered as a part of this study include Bio Products Laboratory, MassBiologics, Saol Therapeutics, Aptevo Biotherapeutics Llc and Ki Biopharma Llc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Human Varicella-Zoster Immunoglobulin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Freeze-dried Powder
  • Injection

Market segment by Application

  • Hospital
  • Clinic

Major players covered

  • Bio Products Laboratory
  • MassBiologics
  • Saol Therapeutics
  • Aptevo Biotherapeutics Llc
  • Ki Biopharma Llc
  • Cangene Biopharma
  • Kamada
  • Salmedon

Market segment by region, regional analysis covers

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Human Varicella-Zoster Immunoglobulin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Varicella-Zoster Immunoglobulin, with price, sales, revenue and global market share of Human Varicella-Zoster Immunoglobulin from 2018 to 2023.
Chapter 3, the Human Varicella-Zoster Immunoglobulin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Varicella-Zoster Immunoglobulin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Varicella-Zoster Immunoglobulin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Varicella-Zoster Immunoglobulin.
Chapter 14 and 15, to describe Human Varicella-Zoster Immunoglobulin sales channel, distributors, customers, research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Human Varicella-Zoster Immunoglobulin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Varicella-Zoster Immunoglobulin Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Freeze-dried Powder
1.3.3 Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Varicella-Zoster Immunoglobulin Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Human Varicella-Zoster Immunoglobulin Market Size & Forecast
1.5.1 Global Human Varicella-Zoster Immunoglobulin Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Varicella-Zoster Immunoglobulin Sales Quantity (2018-2029)
1.5.3 Global Human Varicella-Zoster Immunoglobulin Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bio Products Laboratory
2.1.1 Bio Products Laboratory Details
2.1.2 Bio Products Laboratory Major Business
2.1.3 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Product and Services
2.1.4 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bio Products Laboratory Recent Developments/Updates
2.2 MassBiologics
2.2.1 MassBiologics Details
2.2.2 MassBiologics Major Business
2.2.3 MassBiologics Human Varicella-Zoster Immunoglobulin Product and Services
2.2.4 MassBiologics Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 MassBiologics Recent Developments/Updates
2.3 Saol Therapeutics
2.3.1 Saol Therapeutics Details
2.3.2 Saol Therapeutics Major Business
2.3.3 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Product and Services
2.3.4 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Saol Therapeutics Recent Developments/Updates
2.4 Aptevo Biotherapeutics Llc
2.4.1 Aptevo Biotherapeutics Llc Details
2.4.2 Aptevo Biotherapeutics Llc Major Business
2.4.3 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Product and Services
2.4.4 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Aptevo Biotherapeutics Llc Recent Developments/Updates
2.5 Ki Biopharma Llc
2.5.1 Ki Biopharma Llc Details
2.5.2 Ki Biopharma Llc Major Business
2.5.3 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Product and Services
2.5.4 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Ki Biopharma Llc Recent Developments/Updates
2.6 Cangene Biopharma
2.6.1 Cangene Biopharma Details
2.6.2 Cangene Biopharma Major Business
2.6.3 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Product and Services
2.6.4 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cangene Biopharma Recent Developments/Updates
2.7 Kamada
2.7.1 Kamada Details
2.7.2 Kamada Major Business
2.7.3 Kamada Human Varicella-Zoster Immunoglobulin Product and Services
2.7.4 Kamada Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Kamada Recent Developments/Updates
2.8 Salmedon
2.8.1 Salmedon Details
2.8.2 Salmedon Major Business
2.8.3 Salmedon Human Varicella-Zoster Immunoglobulin Product and Services
2.8.4 Salmedon Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Salmedon Recent Developments/Updates
3 Competitive Environment: Human Varicella-Zoster Immunoglobulin by Manufacturer
3.1 Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Varicella-Zoster Immunoglobulin Revenue by Manufacturer (2018-2023)
3.3 Global Human Varicella-Zoster Immunoglobulin Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Varicella-Zoster Immunoglobulin by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Varicella-Zoster Immunoglobulin Manufacturer Market Share in 2022
3.4.2 Top 6 Human Varicella-Zoster Immunoglobulin Manufacturer Market Share in 2022
3.5 Human Varicella-Zoster Immunoglobulin Market: Overall Company Footprint Analysis
3.5.1 Human Varicella-Zoster Immunoglobulin Market: Region Footprint
3.5.2 Human Varicella-Zoster Immunoglobulin Market: Company Product Type Footprint
3.5.3 Human Varicella-Zoster Immunoglobulin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Human Varicella-Zoster Immunoglobulin Market Size by Region
4.1.1 Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Region (2018-2029)
4.1.2 Global Human Varicella-Zoster Immunoglobulin Consumption Value by Region (2018-2029)
4.1.3 Global Human Varicella-Zoster Immunoglobulin Average Price by Region (2018-2029)
4.2 North America Human Varicella-Zoster Immunoglobulin Consumption Value (2018-2029)
4.3 Europe Human Varicella-Zoster Immunoglobulin Consumption Value (2018-2029)
4.4 Asia-Pacific Human Varicella-Zoster Immunoglobulin Consumption Value (2018-2029)
4.5 South America Human Varicella-Zoster Immunoglobulin Consumption Value (2018-2029)
4.6 Middle East and Africa Human Varicella-Zoster Immunoglobulin Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2029)
5.2 Global Human Varicella-Zoster Immunoglobulin Consumption Value by Type (2018-2029)
5.3 Global Human Varicella-Zoster Immunoglobulin Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2029)
6.2 Global Human Varicella-Zoster Immunoglobulin Consumption Value by Application (2018-2029)
6.3 Global Human Varicella-Zoster Immunoglobulin Average Price by Application (2018-2029)
7 North America
7.1 North America Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2029)
7.2 North America Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2029)
7.3 North America Human Varicella-Zoster Immunoglobulin Market Size by Country
7.3.1 North America Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2018-2029)
7.3.2 North America Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2029)
8.2 Europe Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2029)
8.3 Europe Human Varicella-Zoster Immunoglobulin Market Size by Country
8.3.1 Europe Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Varicella-Zoster Immunoglobulin Market Size by Region
9.3.1 Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Varicella-Zoster Immunoglobulin Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2029)
10.2 South America Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2029)
10.3 South America Human Varicella-Zoster Immunoglobulin Market Size by Country
10.3.1 South America Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2018-2029)
10.3.2 South America Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Varicella-Zoster Immunoglobulin Market Size by Country
11.3.1 Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Human Varicella-Zoster Immunoglobulin Market Drivers
12.2 Human Varicella-Zoster Immunoglobulin Market Restraints
12.3 Human Varicella-Zoster Immunoglobulin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Human Varicella-Zoster Immunoglobulin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Varicella-Zoster Immunoglobulin
13.3 Human Varicella-Zoster Immunoglobulin Production Process
13.4 Human Varicella-Zoster Immunoglobulin Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Varicella-Zoster Immunoglobulin Typical Distributors
14.3 Human Varicella-Zoster Immunoglobulin Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock